An initial investigation of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy.

BACKGROUND AND AIMS: Bispectral (BIS) monitoring has been used to evaluate depth of sedation in intensive care and surgical patients. We sought to explore its utility as a monitoring device for nurse-administered propofol sedation (NAPS) during colonoscopy.

METHODS: Fifty consecutive patients (ASA I or II) receiving NAPS for outpatient colonoscopy were evaluated. BIS scores, sedation scores, and propofol dosing were correlated. The nurses assessed the usefulness of BIS by questionnaire.

RESULTS: The mean (SD) dose of propofol required to produce a BIS value /= 90 or return to baseline (570 +/- 279.9 s, p < 0.0001). The mean (SD) BIS value in the maintenance phase of sedation was 58.9 (8.53), with a range of 22-88. Nurses administering propofol rated the usefulness of BIS at a mean of 2.85 (maximum usefulness scored as 4) in guiding the dosing of propofol sedation during the maintenance phase of sedation. No patient required mask ventilation or endotracheal intubation.

CONCLUSIONS: The BIS index in its current version is not useful in titrating boluses of propofol to an adequate level of sedation, because there is a substantial lag time between decrease of BIS scores to <70 and OAA/S scores indicative of deep sedation. There is also a substantial lag time between recovery of alertness and return of BIS scores to normal. A controlled trial of whether BIS values can assist in avoiding unnecessary propofol dosing during the maintenance phase of sedation appears warranted.